ANTISENSE MODULATION OF EIF2C1 EXPRESSION

Details for Australian Patent Application No. 2002360337 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors WATT, Andrew, T.; WARD, Donna, T.

Pub. Number AU-A-2002360337

PCT Number PCT/US02/35324

PCT Pub. Number WO2003/040321

Priority 10/007,078 08.11.01 US

Filing date 4 November 2002

Wipo publication date 19 May 2003

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 10/007,078 08.11.01 US

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002360337

22 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360338-DIELECTRIC WAVEGUIDE GASFILLED STARK SHIFT MODULATOR

2002360336-ANTISENSE MODULATION OF HUMAN COLLAPSIN RESPONSE MEDIATOR PROTEIN 2 EXPRESSION